FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 303:788-795 October 2, 1980 Number 14 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We studied the mechanism of platelet injury in 20 patients receiving heparin, three of whom became thrombocytopenic. Platelets from these three patients had increased levels of IgG and C3, which correlated with the presence of thrombocytopenia; their plasma caused the release of serotonin from normal platelets at concentrations of heparin within the usual therapeutic range. This reaction required IgG and an intact classic complement pathway. The 17 patients receiving heparin in whom thrombocytopenia did not develop had normal levels of platelet-associated IgG and C3. Plasma from 14 of these patients caused the release of serotonin, but only at heparin concentrations above the therapeutic range, in a reaction that also required IgG and complement. The addition of heparin to 15 normal plasma samples did not cause platelet injury in vitro. These studies indicate that heparin administration can be associated with complement-mediated platlet injury. The dose-dependent nature of this process may account for the occurrence of thrombocytopenia in some of these patients.

This article has been cited by other articles:

• Shelat, S. G., Tomaski, A., Pollak, E. S. (2008). Serologic Results in >1000 Patients With Suspected Heparin-Induced Thrombocytopenia. CLIN APPL THROMB HEMOST 14: 410-414 [Abstract]  
• Kelton, J. G., Warkentin, T. E. (2008). Heparin-induced thrombocytopenia: a historical perspective. Blood 112: 2607-2616 [Full Text]  
• Rauova, L., Poncz, M., McKenzie, S. E., Reilly, M. P., Arepally, G., Weisel, J. W., Nagaswami, C., Cines, D. B., Sachais, B. S. (2005). Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia. Blood 105: 131-138 [Abstract] [Full Text]  
• Gruel, Y., Pouplard, C., Lasne, D., Magdelaine-Beuzelin, C., Charroing, C., Watier, H. (2004). The homozygous Fc{gamma}RIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet factor 4 complexes. Blood 104: 2791-2793 [Abstract] [Full Text]  
• Thai, L. M., Ashman, L. K., Harbour, S. N., Hogarth, P. M., Jackson, D. E. (2003). Physical proximity and functional interplay of PECAM-1 with the Fc receptor Fc{gamma}RIIa on the platelet plasma membrane. Blood 102: 3637-3645 [Abstract] [Full Text]  
• Li, Z. Q., Liu, W., Park, K. S., Sachais, B. S., Arepally, G. M., Cines, D. B., Poncz, M. (2002). Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody. Blood 99: 1230-1236 [Abstract] [Full Text]  
• Blank, M., Shoenfeld, Y., Tavor, S., Praprotnik, S., Boffa, M. C., Weksler, B., Walenga, M. J., Amiral, J., Eldor, A. (2002). Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells. Int Immunol 14: 121-129 [Abstract] [Full Text]  
• Reilly, M. P., Taylor, S. M., Hartman, N. K., Arepally, G. M., Sachais, B. S., Cines, D. B., Poncz, M., McKenzie, S. E. (2001). Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through Fc{gamma}RIIA. Blood 98: 2442-2447 [Abstract] [Full Text]  
• Morris, C. D., Vega, J. D., Levy, J. H., Buist, N. N., Smith, A. L., Despotis, G. J., Kanter, K. R. (2001). Warfarin therapy does not increase bleeding in patients undergoing heart transplantation. Ann. Thorac. Surg. 72: 714-718 [Abstract] [Full Text]  
• Tcheng, J. E., Kereiakes, D. J., Lincoff, A. M., George, B. S., Kleiman, N. S., Sane, D. C., Cines, D. B., Jordan, R. E., Mascelli, M. A., Langrall, M. A., Damaraju, L., Schantz, A., Effron, M. B., Braden, G. A. (2001). Abciximab Readministration: Results of the ReoPro Readministration Registry. Circulation 104: 870-875 [Abstract] [Full Text]  
• Warkentin, T. E., Kelton, J. G. (2001). Temporal Aspects of Heparin-Induced Thrombocytopenia. NEJM 344: 1286-1292 [Abstract] [Full Text]  
• Brinks, H J, Weerwind, P W, Bogdan, S, Verbruggen, H, Brouwer, M H. (2001). Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?. Perfusion 16: 3-12 [Abstract]  
• Taylor, S. M., Reilly, M. P., Schreiber, A. D., Chien, P., Tuckosh, J. R., McKenzie, S. E. (2000). Thrombosis and shock induced by activating antiplatelet antibodies in human Fcgamma RIIA transgenic mice: the interplay among antibody, spleen, and Fc receptor. Blood 96: 4254-4260 [Abstract] [Full Text]  
• Wallis, D. E., Quintos, R., Wehrmacher, W., Messmore, H. (1999). Safety of Warfarin Anticoagulation in Patients With Heparin-Induced Thrombocytopenia. Chest 116: 1333-1338 [Abstract] [Full Text]  
• Ahmad, S., Jeske, W. P., Walenga, J. M., Hoppensteadt, D. A., Wood, J. J., Herbert, J.-M., Messmore, H. L., Fareed, J. (1999). Synthetic Pentasaccharides Do Not Cause Platelet Activation by Antiheparin-Platelet Factor 4 Antibodies. CLIN APPL THROMB HEMOST 5: 259-266 [Abstract]  
• McKenzie, S. E., Taylor, S. M., Malladi, P., Yuhan, H., Cassel, D. L., Chien, P., Schwartz, E., Schreiber, A. D., Surrey, S., Reilly, M. P. (1999). The Role of the Human Fc Receptor Fc{gamma}RIIA in the Immune Clearance of Platelets: A Transgenic Mouse Model. J. Immunol. 162: 4311-4318 [Abstract] [Full Text]  
• Ziporen, L., Li, Z.Q., Park, K.S., Sabnekar, P., Liu, W.Y., Arepally, G., Shoenfeld, Y., Kieber-Emmons, T., Cines, D.B., Poncz, M. (1998). Defining an Antigenic Epitope on Platelet Factor 4 Associated With Heparin-Induced Thrombocytopenia. Blood 92: 3250-3259 [Abstract] [Full Text]  
• Bauer, T. L., Arepally, G., Konkle, B. A., Mestichelli, B., Shapiro, S. S., Cines, D. B., Poncz, M., McNulty, S., Amiral, J., Hauck, W. W., Edie, R. N., Mannion, J. D. (1997). Prevalence of Heparin-Associated Antibodies Without Thrombosis in Patients Undergoing Cardiopulmonary Bypass Surgery. Circulation 95: 1242-1246 [Abstract] [Full Text]  
• Samuels, L. E., Shektman, A., Amrom, G., DiGiovanai, R. J., Dupont, J.-R., Kerstein, M. D. (1992). Heparin-Induced Thrombocytopenia: A Spectrum of Hemorrhage and Thrombosis--Case Presentations. VASC ENDOVASCULAR SURG 26: 596-604 [Abstract]  
• Sobel, M. (1992). Heparin-Induced Thrombocytopenia. PERSPECT VASC SURG ENDOVASC THER 5: 1-27  
• Cohen, D. J., Briggs, R., Head, H. D., Acher, C. W. (1989). Phlegmasia Cerulea Dolens and Its Association with Hypercoagulable States: Case Reports. ANGIOLOGY 40: 498-508 [Abstract]